SCHEMBL7996078

SCHEMBL7996078

CC(=O)O[C@@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.79
LMNA P02545 9/20 0.79
MAPT P10636 6/20 0.79
TSHR P16473 5/20 0.79
NR3C1 P04150 4/20 0.79
PGR P06401 4/20 0.79
AR P10275 4/20 0.79
NR1I2 O75469 3/20 0.79
CYP2C9 P11712 3/20 0.79
CYP2C19 P33261 2/20 0.79
CYP17A1 P05093 1/20 0.79
OPRK1 P41145 1/20 0.79
CYP19A1 P11511 3/20 0.77
ALDH1A1 P00352 6/20 0.71
SMN1; SMN2 Q16637 5/20 0.71
MAPK1 P28482 4/20 0.71
SHBG P04278 4/20 0.71
SERPINA6 P08185 4/20 0.71
GPBAR1 Q8TDU6 3/20 0.71
SIGMAR1 Q99720 3/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617560 1.00 CYP3A4 (0.79) CYP3A4LMNAMAPTTSHRNR3C1
SCHEMBL547898 1.00 CYP3A4 (0.79) CYP3A4LMNAMAPTTSHRNR3C1
SCHEMBL4617563 1.00 CYP3A4 (0.79) CYP3A4LMNAMAPTTSHRNR3C1
SCHEMBL2082800 1.00 CYP3A4 (0.79) CYP3A4LMNAMAPTTSHRNR3C1
SCHEMBL18438757 1.00 CYP3A4 (0.79) CYP3A4LMNAMAPTTSHRNR3C1
SCHEMBL15369348 1.00 CYP3A4 (0.79) CYP3A4LMNAMAPTTSHRNR3C1
SCHEMBL2600420 1.00 CYP3A4 (0.79) CYP3A4LMNAMAPTTSHRNR3C1
Propionic Acid SCHEMBL26659955 0.94 CYP3A4 (0.80) CYP3A4LMNAMAPTTSHRNR3C1
SCHEMBL8814296 0.92 CYP3A4 (0.80) CYP3A4LMNAMAPTTSHRNR3C1
Butyric Acid SCHEMBL26659976 0.91 CYP3A4 (0.73) CYP3A4LMNAMAPTTSHRNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274118-B1 INJECTING PATIENT HAVING ENDOCRINE CANCER IN NON-PROSTATIC TISSUE WITH BIOLOGICAL BINDING UNITS WHICH BIND TO PROSTATE SPECIFIC ANTIGEN PRODUCED BY NON-PROSTATIC TISSUE NORDION INTERNATIONAL INC. (CA) 2001-08-14 US disclosed
WO-1995002424-A1 LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN NORDION INTERNATIONAL INC. (CA) 1995-01-26 WO disclosed